Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System

Pyrazinamide (PZA) is a key antituberculosis drug, yet no rapid susceptibility test is commercially available. PZA drug susceptibility testing (DST) was performed directly on sputum samples from 327 patients and compared with the indirect method by using the Bactec MGIT 960 system in the context of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Microbiol
Autors principals: Demers, Anne-Marie, Venter, Amour, Friedrich, Sven O., Rojas-Ponce, Gabriel, Mapamba, Daniel, Jugheli, Levan, Sasamalo, Mohammed, Almeida, Deepak, Dorasamy, Afton, Jentsch, Ute, Gibson, Mara, Everitt, Daniel, Eisenach, Kathleen D., Diacon, Andreas H.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2016
Matèries:
Mycobacteriology and Aerobic Actinomycetes
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4844746/
https://ncbi.nlm.nih.gov/pubmed/26912751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.03162-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars